iShares Biotechnology ETF (NASDAQ:IBB) Holdings Decreased by Blair William & Co. IL

Blair William & Co. IL reduced its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 7.1% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 47,144 shares of the financial services provider’s stock after selling 3,603 shares during the period. Blair William & Co. IL owned approximately 0.09% of iShares Biotechnology ETF worth $6,471,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Corient Private Wealth LLC raised its position in shares of iShares Biotechnology ETF by 1.0% during the fourth quarter. Corient Private Wealth LLC now owns 86,700 shares of the financial services provider’s stock worth $11,778,000 after purchasing an additional 841 shares during the period. Advisory Services Network LLC lifted its stake in iShares Biotechnology ETF by 132.1% during the fourth quarter. Advisory Services Network LLC now owns 14,926 shares of the financial services provider’s stock valued at $2,028,000 after buying an additional 8,494 shares in the last quarter. Nomura Asset Management Co. Ltd. acquired a new position in shares of iShares Biotechnology ETF in the fourth quarter worth about $2,771,000. Mitchell Sinkler & Starr PA purchased a new position in shares of iShares Biotechnology ETF in the fourth quarter worth approximately $84,000. Finally, Proquility Private Wealth Partners LLC raised its holdings in shares of iShares Biotechnology ETF by 6.1% during the fourth quarter. Proquility Private Wealth Partners LLC now owns 23,579 shares of the financial services provider’s stock valued at $3,203,000 after acquiring an additional 1,358 shares during the period. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Down 1.0 %

Shares of IBB opened at $147.98 on Friday. iShares Biotechnology ETF has a 52 week low of $111.83 and a 52 week high of $150.57. The company’s 50 day moving average price is $145.74 and its 200 day moving average price is $138.54.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.